TBX1 and chordoma: To investigate the in vivo efficiency of the delivery strategy using the VLP-packaged Cas9/brachyury gRNA, we generated a subcutaneous chordoma mouse model and directly injected VLP-packaged Cas9/ primary vectors as control or VLP-packaged Cas9/brachyury gRNA into tumors (Fig. 4a).